This is a genetic condition that affects your immune system. It makes it harder for your body to fight off infections. It's caused by a change in a specific gene and affects males more often than females.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for X-Linked Combined Immunodeficiency?
X-linked combined immunodeficiency is an inherited immune disorder, seen almost only in boys and men, in which the white blood cells called lymphocytes fail to develop or work properly. Lymphocytes include T cells, which direct the immune response and attack infected cells, B cells, which make antibodies, and natural killer (NK) cells. Without them, the body cannot control many bacteria, viruses and fungi. The best-known and most serious form is X-linked severe combined immunodeficiency (X-SCID). A baby with typical X-SCID looks healthy at birth but, without treatment, develops repeated or persistent infections, chronic diarrhea, a fungal mouth infection called thrush, rashes and poor growth, usually within the first months of life. These infections become life-threatening. X-SCID is the most common type of SCID. Less severe forms, often called atypical or leaky X-SCID, leave the immune system partly working. They can appear later in childhood or even adulthood, with frequent chest and sinus infections, stubborn warts, eczema-like skin problems or autoimmune conditions, in which the immune system attacks the body's own tissues.
All forms are caused by changes (variants) in a gene called IL2RG. This gene makes a protein that several immune signals share, and developing lymphocytes need those signals to grow and mature. When the protein is missing, T cells and NK cells barely form, and B cells are present but cannot make useful antibodies on their own. When the protein is only partly faulty, the result is one of the milder forms. The gene sits on the X chromosome. Boys have one X chromosome, so a single altered copy causes the condition. Girls have two, and a working copy on the other X usually protects them, so women who carry the variant are generally healthy. A carrier mother has a 50% chance of passing the variant on in each pregnancy: a son who inherits it will be affected, and a daughter who inherits it will be a carrier. Fathers cannot pass X-linked conditions to their sons, but an affected man will pass the variant to all of his daughters. Some cases arise with no family history. Nothing a parent did during pregnancy causes the condition.
In the United States, most babies with typical X-SCID are now found through newborn screening. Every state tests the routine heel-prick blood sample for T-cell receptor excision circles (TRECs), small pieces of DNA that newly made T cells leave behind. A very low or absent TREC level means the baby is making few new T cells. A low screening result is a signal, not a diagnosis. Premature birth, some genetic syndromes such as DiGeorge syndrome, heart problems and certain medicines taken during pregnancy can also lower T cells. Follow-up blood tests count the different types of lymphocytes, check whether T cells respond when stimulated, and measure antibody levels. The typical pattern in X-SCID is very few T and NK cells with B cells still present. Genetic testing that finds a variant in IL2RG confirms the diagnosis and allows other relatives to be tested. The milder forms usually do not show up on newborn screening, because enough T cells may be made to pass the test. They are often diagnosed later, after a pattern of unusual or repeated infections leads to immune testing and then genetic testing. When a family's variant is already known, testing can be done during pregnancy or right after birth.
Typical X-SCID is fatal without treatment that gives the child a working immune system. The main treatment is a hematopoietic stem cell transplant (HSCT), in which blood-forming stem cells from a donor are given to the baby so they can grow into healthy immune cells. A brother or sister whose tissue type matches is the ideal donor; survival is above 90% with such a match, and other donors, such as a parent or an unrelated donor, are used when no matched sibling exists. Some transplants are done with little or no chemotherapy beforehand (called conditioning). That avoids some of chemotherapy's harms, but it can leave antibody production or other parts of the immune system incomplete. Gene therapy is another approach. A child's own stem cells are collected, a working copy of IL2RG is added in the laboratory, and the cells are returned. Early versions restored T cells but caused leukemia in some children; newer versions using a different kind of carrier virus have shown lasting recovery of T, B and NK cells in trials. It is offered mainly through clinical trials at a few specialized centers. While a baby waits for transplant, care focuses on preventing infection. Babies receive regular immunoglobulin, which supplies antibodies made from donated blood, along with preventive antibiotic, antifungal and antiviral medicines. Families keep the baby away from crowds, young children and anyone who is sick. Live vaccines, including the rotavirus vaccine, are not given, and household members are usually asked to avoid live vaccines too. Breastfeeding is paused until the mother is tested for cytomegalovirus (CMV), a common virus that can pass through breast milk and be dangerous to a baby without T cells. Any blood transfusion must use irradiated blood. For the milder forms, treatment depends on how severe the infections and immune problems are. It may include immunoglobulin, preventive antibiotics, medicines that calm an overactive immune system, and in some people a stem cell transplant.
For a baby with typical X-SCID, the outlook depends heavily on timing. Children treated early, before serious infections take hold, do best: in a large North American study, about 92 to 93 of every 100 babies found through newborn screening were alive five years after transplant. Before screening, when babies were usually diagnosed only after becoming ill, survival was closer to 72 out of 100. The weeks before transplant are demanding. Families live with strict infection precautions, frequent appointments and sometimes long stays near a transplant center. Social work and family support are a normal part of care, and many parents find the period stressful even when things go well. After a successful transplant, the new immune system builds up gradually, and follow-up continues for years. Visits every 6 to 12 months typically check how well the donor cells have taken hold, immune function, growth, lungs, digestion and skin. Some children still need immunoglobulin long term because their B cells do not fully recover, and some develop persistent warts. Children who received chemotherapy before transplant also need long-term checks of organ function and development. People with the milder forms often have a long-term course of recurring infections and immune problems that need ongoing care from an immunologist, with treatment adjusted over time.
If a newborn's screening test shows low TRECs, follow up right away: the baby needs prompt evaluation by an immunology specialist, ideally at a center experienced in SCID, and should be kept away from sick people in the meantime. If X-SCID or another immunodeficiency runs in the family, tell the obstetric and pediatric teams before birth so a newborn boy can be tested and protected immediately. For a baby already diagnosed and waiting for treatment, contact the immunology team right away about fever, cough, breathing changes, diarrhea, a new rash or poor feeding, since infection before transplant is the main threat to a good outcome. At any age, ask for an immune evaluation if a child or adult has repeated or unusually severe infections, thrush that keeps returning, ongoing diarrhea with poor growth, or infections that do not clear with usual treatment, especially with a family history of immune disorders.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with X-Linked Combined Immunodeficiency is like, what's helped you, or ask the community a question.